Share Price and Basic Stock Data
Last Updated: November 3, 2025, 10:08 pm
| PEG Ratio | -5.95 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Sudarshan Chemical Industries Ltd operates in the Dyes & Pigments sector, with its share price recently reported at ₹1,178 and a market capitalization of ₹9,261 Cr. The company has shown a steady revenue growth trajectory, with total sales rising from ₹2,201 Cr in March 2022 to ₹2,302 Cr in March 2023, and projected to reach ₹3,346 Cr by March 2025. The trailing twelve months (TTM) revenue stood at ₹5,219 Cr, reflecting a robust performance. Quarterly sales also demonstrated variability; for instance, sales peaked at ₹764.24 Cr in March 2024, illustrating seasonal fluctuations and potential recovery post-pandemic. The overall industry outlook remains positive, with demand for dyes and pigments expected to grow as global markets expand. However, the company’s operating profit margin (OPM) was recorded at 9.41%, which, while acceptable, is lower than the industry average, indicating a need for operational efficiencies to enhance profitability.
Profitability and Efficiency Metrics
The profitability metrics of Sudarshan Chemical reflect a mixed bag. The company reported a net profit of ₹86 Cr for the latest fiscal year, with a profit before tax of ₹99 Cr. The return on equity (ROE) stood at a modest 3.07%, while the return on capital employed (ROCE) was recorded at 6.03%. These figures are relatively low compared to typical sector benchmarks, suggesting that while the company is generating profits, it may not be utilizing its equity and capital as efficiently as competitors in the Dyes & Pigments industry. Additionally, the interest coverage ratio (ICR) of 8.58x indicates a strong ability to meet interest obligations, which is a positive sign for investors. However, the cash conversion cycle (CCC) is notably long at 353 days, which could hinder liquidity and operational efficiency. Overall, while the company is profitable, it must address its efficiency metrics to improve its competitive position.
Balance Sheet Strength and Financial Ratios
Sudarshan Chemical’s balance sheet shows significant resilience, with total assets reported at ₹9,672 Cr and total liabilities at ₹9,672 Cr as well. The company has reserves amounting to ₹3,424 Cr, indicating a solid foundation for future investments and growth. However, borrowings have escalated to ₹2,378 Cr, raising concerns about financial leverage. The debt-to-equity ratio stood at 0.60, which is relatively high and could pose risks if economic conditions worsen. The price-to-book value (P/BV) ratio is recorded at 2.26x, which suggests the stock is trading at a premium relative to its book value, indicating market confidence but also a potential overvaluation. Furthermore, the current ratio of 2.12 and quick ratio of 1.27 suggest adequate liquidity to meet short-term obligations, providing a cushion against financial distress. Overall, the balance sheet is robust, but increased leverage warrants close monitoring.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sudarshan Chemical Industries reveals a diverse investor base, with promoters holding 16.41% of the company as of the latest report. Foreign institutional investors (FIIs) account for 8.52%, while domestic institutional investors (DIIs) hold 23.51%. Public shareholders make up 51.57%, indicating broad market participation. The reduction in promoter holding, which was 35.82% in March 2023, raises questions about insider confidence and may affect market perception. Nonetheless, the relatively high institutional ownership suggests confidence among institutional investors. The number of shareholders has declined from 75,769 in September 2022 to 64,728, indicating a potential consolidation phase. This shift could reflect broader market trends or investor sentiment towards the company, emphasizing the need for Sudarshan Chemical to enhance shareholder value to retain and attract investors.
Outlook, Risks, and Final Insight
The outlook for Sudarshan Chemical Industries appears cautiously optimistic, with growth potential in the Dyes & Pigments market driven by increasing demand. However, several risks loom, including its high debt levels, which could affect profitability if interest rates rise or market conditions deteriorate. Additionally, the lengthy cash conversion cycle may impact liquidity, especially if operational efficiencies are not improved. The company must also navigate fluctuating raw material costs, which can affect margins. Strengths include a solid balance sheet with significant reserves and a diverse shareholder base, which may provide stability in turbulent times. In conclusion, while Sudarshan Chemical has the potential for growth, it must address its efficiency and leverage concerns to capitalize on market opportunities effectively. A focus on enhancing operational efficiency and managing debt levels will be critical for its sustained success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Sudarshan Chemical Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dynamic Industries Ltd | 49.1 Cr. | 162 | 190/68.5 | 25.7 | 159 | 0.62 % | 5.68 % | 3.39 % | 10.0 |
| Daikaffil Chemicals India Ltd | 68.5 Cr. | 114 | 281/108 | 14.8 | 0.00 % | 18.6 % | 18.6 % | 10.0 | |
| Amal Ltd | 906 Cr. | 733 | 1,148/393 | 23.4 | 91.7 | 0.14 % | 36.3 % | 35.0 % | 10.0 |
| Vidhi Specialty Food Ingredients Ltd | 1,691 Cr. | 336 | 572/328 | 35.4 | 60.5 | 1.49 % | 18.7 % | 14.9 % | 1.00 |
| Ushanti Colour Chem Ltd | 46.4 Cr. | 41.2 | 67.1/38.0 | 39.6 | 0.00 % | 0.98 % | 5.98 % | 10.0 | |
| Industry Average | 1,482.62 Cr | 331.07 | 35.29 | 187.69 | 0.36% | 11.00% | 9.10% | 8.13 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 627.15 | 554.16 | 528.38 | 528.02 | 691.18 | 608.11 | 600.68 | 565.75 | 764.24 | 633.62 | 696.09 | 666.43 | 1,349.44 |
| Expenses | 541.07 | 512.74 | 485.51 | 486.38 | 606.46 | 538.23 | 535.10 | 503.88 | 645.16 | 553.05 | 601.60 | 587.44 | 1,222.45 |
| Operating Profit | 86.08 | 41.42 | 42.87 | 41.64 | 84.72 | 69.88 | 65.58 | 61.87 | 119.08 | 80.57 | 94.49 | 78.99 | 126.99 |
| OPM % | 13.73% | 7.47% | 8.11% | 7.89% | 12.26% | 11.49% | 10.92% | 10.94% | 15.58% | 12.72% | 13.57% | 11.85% | 9.41% |
| Other Income | 1.71 | 0.84 | 1.42 | 0.99 | 1.54 | 319.24 | 5.69 | 4.28 | 2.99 | 3.50 | -6.19 | -26.34 | -38.33 |
| Interest | 5.46 | 6.06 | 9.34 | 11.02 | 15.05 | 10.31 | 9.63 | 8.58 | 8.38 | 7.03 | 8.88 | 11.41 | 20.96 |
| Depreciation | 24.80 | 25.80 | 26.95 | 30.91 | 30.56 | 34.60 | 35.42 | 35.48 | 35.67 | 35.93 | 36.61 | 36.55 | 57.14 |
| Profit before tax | 57.53 | 10.40 | 8.00 | 0.70 | 40.65 | 344.21 | 26.22 | 22.09 | 78.02 | 41.11 | 42.81 | 4.69 | 10.56 |
| Tax % | 22.37% | 31.92% | 43.25% | 17.14% | 19.85% | 22.44% | 31.88% | 33.91% | 25.61% | 28.39% | 30.13% | 89.13% | 97.06% |
| Net Profit | 44.66 | 7.08 | 4.54 | 0.58 | 32.57 | 266.96 | 17.86 | 14.59 | 58.03 | 29.43 | 29.90 | 0.51 | 0.31 |
| EPS in Rs | 6.45 | 1.02 | 0.66 | 0.08 | 4.70 | 38.56 | 2.58 | 2.11 | 8.38 | 4.25 | 4.32 | 0.07 | -0.52 |
Last Updated: August 1, 2025, 11:00 am
Below is a detailed analysis of the quarterly data for Sudarshan Chemical Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 1,349.44 Cr.. The value appears strong and on an upward trend. It has increased from 666.43 Cr. (Dec 2024) to 1,349.44 Cr., marking an increase of 683.01 Cr..
- For Expenses, as of Mar 2025, the value is 1,222.45 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 587.44 Cr. (Dec 2024) to 1,222.45 Cr., marking an increase of 635.01 Cr..
- For Operating Profit, as of Mar 2025, the value is 126.99 Cr.. The value appears strong and on an upward trend. It has increased from 78.99 Cr. (Dec 2024) to 126.99 Cr., marking an increase of 48.00 Cr..
- For OPM %, as of Mar 2025, the value is 9.41%. The value appears to be declining and may need further review. It has decreased from 11.85% (Dec 2024) to 9.41%, marking a decrease of 2.44%.
- For Other Income, as of Mar 2025, the value is -38.33 Cr.. The value appears to be declining and may need further review. It has decreased from -26.34 Cr. (Dec 2024) to -38.33 Cr., marking a decrease of 11.99 Cr..
- For Interest, as of Mar 2025, the value is 20.96 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.41 Cr. (Dec 2024) to 20.96 Cr., marking an increase of 9.55 Cr..
- For Depreciation, as of Mar 2025, the value is 57.14 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.55 Cr. (Dec 2024) to 57.14 Cr., marking an increase of 20.59 Cr..
- For Profit before tax, as of Mar 2025, the value is 10.56 Cr.. The value appears strong and on an upward trend. It has increased from 4.69 Cr. (Dec 2024) to 10.56 Cr., marking an increase of 5.87 Cr..
- For Tax %, as of Mar 2025, the value is 97.06%. The value appears to be increasing, which may not be favorable. It has increased from 89.13% (Dec 2024) to 97.06%, marking an increase of 7.93%.
- For Net Profit, as of Mar 2025, the value is 0.31 Cr.. The value appears to be declining and may need further review. It has decreased from 0.51 Cr. (Dec 2024) to 0.31 Cr., marking a decrease of 0.20 Cr..
- For EPS in Rs, as of Mar 2025, the value is -0.52. The value appears to be declining and may need further review. It has decreased from 0.07 (Dec 2024) to -0.52, marking a decrease of 0.59.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:22 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,106 | 1,205 | 1,401 | 1,282 | 1,329 | 1,593 | 1,708 | 1,864 | 2,201 | 2,302 | 2,539 | 3,346 | 5,219 |
| Expenses | 974 | 1,075 | 1,232 | 1,093 | 1,139 | 1,386 | 1,460 | 1,574 | 1,923 | 2,088 | 2,220 | 2,962 | 4,726 |
| Operating Profit | 133 | 131 | 170 | 189 | 191 | 207 | 248 | 290 | 278 | 213 | 318 | 383 | 493 |
| OPM % | 12% | 11% | 12% | 15% | 14% | 13% | 15% | 16% | 13% | 9% | 13% | 11% | 9% |
| Other Income | 2 | 23 | 14 | 25 | 15 | 81 | 22 | 7 | 5 | 5 | 332 | -67 | -38 |
| Interest | 43 | 41 | 37 | 30 | 25 | 19 | 16 | 20 | 23 | 44 | 39 | 51 | 85 |
| Depreciation | 37 | 42 | 48 | 49 | 58 | 66 | 74 | 87 | 89 | 114 | 141 | 166 | 229 |
| Profit before tax | 55 | 72 | 99 | 136 | 123 | 203 | 180 | 190 | 171 | 60 | 471 | 99 | 140 |
| Tax % | 37% | 24% | 29% | 25% | 31% | 33% | 20% | 26% | 24% | 25% | 24% | 39% | |
| Net Profit | 35 | 54 | 70 | 101 | 85 | 135 | 145 | 141 | 130 | 45 | 357 | 60 | 86 |
| EPS in Rs | 5.08 | 7.86 | 10.10 | 14.64 | 12.24 | 19.52 | 20.88 | 20.38 | 18.77 | 6.47 | 51.63 | 7.10 | 9.88 |
| Dividend Payout % | 30% | 22% | 30% | 24% | 29% | 31% | 30% | 29% | 27% | 23% | 9% | 63% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 54.29% | 29.63% | 44.29% | -15.84% | 58.82% | 7.41% | -2.76% | -7.80% | -65.38% | 693.33% | -83.19% |
| Change in YoY Net Profit Growth (%) | 0.00% | -24.66% | 14.66% | -60.13% | 74.67% | -51.42% | -10.17% | -5.04% | -57.58% | 758.72% | -776.53% |
Sudarshan Chemical Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 14% |
| 3 Years: | 15% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -11% |
| 3 Years: | -18% |
| TTM: | -35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 26% |
| 3 Years: | 46% |
| 1 Year: | 36% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:36 pm
Balance Sheet
Last Updated: September 10, 2025, 2:34 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 16 |
| Reserves | 264 | 249 | 300 | 367 | 426 | 554 | 587 | 730 | 819 | 814 | 1,135 | 3,424 |
| Borrowings | 440 | 433 | 430 | 433 | 431 | 367 | 501 | 618 | 823 | 829 | 467 | 2,378 |
| Other Liabilities | 217 | 317 | 346 | 379 | 433 | 424 | 522 | 638 | 705 | 725 | 730 | 3,854 |
| Total Liabilities | 929 | 1,012 | 1,090 | 1,193 | 1,304 | 1,358 | 1,624 | 2,000 | 2,361 | 2,383 | 2,346 | 9,672 |
| Fixed Assets | 327 | 333 | 358 | 452 | 475 | 465 | 627 | 615 | 832 | 1,126 | 1,102 | 2,958 |
| CWIP | 7 | 8 | 15 | 8 | 6 | 24 | 48 | 278 | 285 | 44 | 15 | 140 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 548 |
| Other Assets | 594 | 671 | 716 | 733 | 822 | 869 | 948 | 1,105 | 1,243 | 1,210 | 1,227 | 6,026 |
| Total Assets | 929 | 1,012 | 1,090 | 1,193 | 1,304 | 1,358 | 1,624 | 2,000 | 2,361 | 2,383 | 2,346 | 9,672 |
Below is a detailed analysis of the balance sheet data for Sudarshan Chemical Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2024) to 16.00 Cr., marking an increase of 2.00 Cr..
- For Reserves, as of Mar 2025, the value is 3,424.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,135.00 Cr. (Mar 2024) to 3,424.00 Cr., marking an increase of 2,289.00 Cr..
- For Borrowings, as of Mar 2025, the value is 2,378.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 467.00 Cr. (Mar 2024) to 2,378.00 Cr., marking an increase of 1,911.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 3,854.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 730.00 Cr. (Mar 2024) to 3,854.00 Cr., marking an increase of 3,124.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 9,672.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,346.00 Cr. (Mar 2024) to 9,672.00 Cr., marking an increase of 7,326.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 2,958.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,102.00 Cr. (Mar 2024) to 2,958.00 Cr., marking an increase of 1,856.00 Cr..
- For CWIP, as of Mar 2025, the value is 140.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2024) to 140.00 Cr., marking an increase of 125.00 Cr..
- For Investments, as of Mar 2025, the value is 548.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 548.00 Cr., marking an increase of 546.00 Cr..
- For Other Assets, as of Mar 2025, the value is 6,026.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,227.00 Cr. (Mar 2024) to 6,026.00 Cr., marking an increase of 4,799.00 Cr..
- For Total Assets, as of Mar 2025, the value is 9,672.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,346.00 Cr. (Mar 2024) to 9,672.00 Cr., marking an increase of 7,326.00 Cr..
Notably, the Reserves (3,424.00 Cr.) exceed the Borrowings (2,378.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -307.00 | -302.00 | -260.00 | -244.00 | -240.00 | -160.00 | -253.00 | -328.00 | -545.00 | -616.00 | -149.00 | 381.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 85 | 96 | 92 | 98 | 92 | 79 | 78 | 95 | 83 | 77 | 84 | 134 |
| Inventory Days | 144 | 125 | 113 | 134 | 131 | 119 | 154 | 142 | 163 | 132 | 113 | 507 |
| Days Payable | 63 | 94 | 96 | 139 | 126 | 94 | 139 | 152 | 150 | 136 | 132 | 288 |
| Cash Conversion Cycle | 166 | 127 | 109 | 93 | 96 | 105 | 92 | 85 | 96 | 73 | 65 | 353 |
| Working Capital Days | 41 | 26 | 40 | 14 | 43 | 51 | 24 | 29 | 18 | 23 | 40 | 154 |
| ROCE % | 14% | 16% | 19% | 22% | 18% | 17% | 18% | 17% | 13% | 6% | 11% | 6% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Axis Small Cap Fund | 2,440,688 | 0.72 | 133.99 | 2,440,688 | 2025-04-22 17:25:20 | 0% |
| Mirae Asset Midcap Fund | 1,788,333 | 0.71 | 98.18 | 1,788,333 | 2025-04-22 17:25:20 | 0% |
| ICICI Prudential Smallcap Fund | 1,540,140 | 1.19 | 84.55 | 1,540,140 | 2025-04-22 17:25:20 | 0% |
| Mirae Asset Multicap Fund | 252,997 | 0.63 | 13.89 | 252,997 | 2025-04-22 16:51:54 | 0% |
| Axis Multi Asset Allocation Fund | 195,318 | 0.87 | 10.72 | 195,318 | 2025-04-22 17:25:20 | 0% |
| Axis Children's Gift Fund Compulsory Lock-in - Regular Plan | 61,836 | 0.42 | 3.39 | 61,836 | 2025-04-22 17:25:20 | 0% |
| Axis Children's Gift Fund No Lock-in - Regular Plan | 61,836 | 0.42 | 3.39 | 61,836 | 2025-04-22 17:25:20 | 0% |
| Motilal Oswal Nifty Microcap 250 Index Fund | 49,922 | 0.44 | 2.74 | 49,922 | 2025-04-22 17:25:20 | 0% |
| LIC MF Small Cap Fund | 900 | 0.03 | 0.05 | 900 | 2025-04-22 17:25:20 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 22.50 | 51.60 | 6.50 | 18.80 | 20.40 |
| Diluted EPS (Rs.) | 22.50 | 51.60 | 6.50 | 18.70 | 20.40 |
| Cash EPS (Rs.) | 28.45 | 72.03 | 22.97 | 31.67 | 32.88 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 437.80 | 165.99 | 119.64 | 120.36 | 107.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 437.80 | 165.99 | 119.64 | 120.36 | 107.41 |
| Revenue From Operations / Share (Rs.) | 425.78 | 366.74 | 332.50 | 317.92 | 269.28 |
| PBDIT / Share (Rs.) | 52.74 | 48.18 | 31.12 | 40.42 | 42.58 |
| PBIT / Share (Rs.) | 31.59 | 27.78 | 14.62 | 27.53 | 30.08 |
| PBT / Share (Rs.) | 12.26 | 67.97 | 8.63 | 24.72 | 27.50 |
| Net Profit / Share (Rs.) | 7.29 | 51.64 | 6.47 | 18.77 | 20.38 |
| NP After MI And SOA / Share (Rs.) | 7.10 | 51.64 | 6.47 | 18.77 | 20.38 |
| PBDIT Margin (%) | 12.38 | 13.13 | 9.35 | 12.71 | 15.81 |
| PBIT Margin (%) | 7.41 | 7.57 | 4.39 | 8.65 | 11.17 |
| PBT Margin (%) | 2.87 | 18.53 | 2.59 | 7.77 | 10.21 |
| Net Profit Margin (%) | 1.71 | 14.07 | 1.94 | 5.90 | 7.56 |
| NP After MI And SOA Margin (%) | 1.66 | 14.07 | 1.94 | 5.90 | 7.56 |
| Return on Networth / Equity (%) | 1.62 | 31.10 | 5.40 | 15.59 | 18.97 |
| Return on Capital Employeed (%) | 3.64 | 12.88 | 7.23 | 14.59 | 18.20 |
| Return On Assets (%) | 0.57 | 15.17 | 1.87 | 5.48 | 7.04 |
| Long Term Debt / Equity (X) | 0.47 | 0.16 | 0.54 | 0.44 | 0.41 |
| Total Debt / Equity (X) | 0.60 | 0.38 | 0.98 | 0.98 | 0.65 |
| Asset Turnover Ratio (%) | 0.55 | 1.07 | 0.87 | 0.90 | 0.96 |
| Current Ratio (X) | 2.12 | 1.38 | 1.17 | 1.13 | 1.20 |
| Quick Ratio (X) | 1.27 | 0.87 | 0.67 | 0.60 | 0.72 |
| Inventory Turnover Ratio (X) | 2.31 | 2.96 | 2.48 | 2.82 | 2.64 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 9.87 | 77.31 | 31.95 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 7.08 | 21.77 | 18.94 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 90.13 | 22.69 | 68.05 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 92.92 | 78.23 | 81.06 | 0.00 |
| Interest Coverage Ratio (X) | 8.58 | 9.04 | 5.19 | 14.41 | 16.49 |
| Interest Coverage Ratio (Post Tax) (X) | 4.33 | 2.15 | 2.08 | 7.69 | 8.90 |
| Enterprise Value (Cr.) | 8962.37 | 4605.33 | 3488.90 | 4384.53 | 4055.41 |
| EV / Net Operating Revenue (X) | 2.68 | 1.81 | 1.52 | 1.99 | 2.18 |
| EV / EBITDA (X) | 21.63 | 13.81 | 16.19 | 15.67 | 13.76 |
| MarketCap / Net Operating Revenue (X) | 2.33 | 1.66 | 1.17 | 1.64 | 1.93 |
| Retention Ratios (%) | 0.00 | 90.12 | 22.68 | 68.04 | 0.00 |
| Price / BV (X) | 2.26 | 3.67 | 3.26 | 4.32 | 4.83 |
| Price / Net Operating Revenue (X) | 2.33 | 1.66 | 1.17 | 1.64 | 1.93 |
| EarningsYield | 0.01 | 0.08 | 0.01 | 0.03 | 0.03 |
After reviewing the key financial ratios for Sudarshan Chemical Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 22.50. This value is within the healthy range. It has decreased from 51.60 (Mar 24) to 22.50, marking a decrease of 29.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is 22.50. This value is within the healthy range. It has decreased from 51.60 (Mar 24) to 22.50, marking a decrease of 29.10.
- For Cash EPS (Rs.), as of Mar 25, the value is 28.45. This value is within the healthy range. It has decreased from 72.03 (Mar 24) to 28.45, marking a decrease of 43.58.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 437.80. It has increased from 165.99 (Mar 24) to 437.80, marking an increase of 271.81.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 437.80. It has increased from 165.99 (Mar 24) to 437.80, marking an increase of 271.81.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 425.78. It has increased from 366.74 (Mar 24) to 425.78, marking an increase of 59.04.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 52.74. This value is within the healthy range. It has increased from 48.18 (Mar 24) to 52.74, marking an increase of 4.56.
- For PBIT / Share (Rs.), as of Mar 25, the value is 31.59. This value is within the healthy range. It has increased from 27.78 (Mar 24) to 31.59, marking an increase of 3.81.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.26. This value is within the healthy range. It has decreased from 67.97 (Mar 24) to 12.26, marking a decrease of 55.71.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 7.29. This value is within the healthy range. It has decreased from 51.64 (Mar 24) to 7.29, marking a decrease of 44.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.10. This value is within the healthy range. It has decreased from 51.64 (Mar 24) to 7.10, marking a decrease of 44.54.
- For PBDIT Margin (%), as of Mar 25, the value is 12.38. This value is within the healthy range. It has decreased from 13.13 (Mar 24) to 12.38, marking a decrease of 0.75.
- For PBIT Margin (%), as of Mar 25, the value is 7.41. This value is below the healthy minimum of 10. It has decreased from 7.57 (Mar 24) to 7.41, marking a decrease of 0.16.
- For PBT Margin (%), as of Mar 25, the value is 2.87. This value is below the healthy minimum of 10. It has decreased from 18.53 (Mar 24) to 2.87, marking a decrease of 15.66.
- For Net Profit Margin (%), as of Mar 25, the value is 1.71. This value is below the healthy minimum of 5. It has decreased from 14.07 (Mar 24) to 1.71, marking a decrease of 12.36.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.66. This value is below the healthy minimum of 8. It has decreased from 14.07 (Mar 24) to 1.66, marking a decrease of 12.41.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.62. This value is below the healthy minimum of 15. It has decreased from 31.10 (Mar 24) to 1.62, marking a decrease of 29.48.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.64. This value is below the healthy minimum of 10. It has decreased from 12.88 (Mar 24) to 3.64, marking a decrease of 9.24.
- For Return On Assets (%), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 5. It has decreased from 15.17 (Mar 24) to 0.57, marking a decrease of 14.60.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.47. This value is within the healthy range. It has increased from 0.16 (Mar 24) to 0.47, marking an increase of 0.31.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.60. This value is within the healthy range. It has increased from 0.38 (Mar 24) to 0.60, marking an increase of 0.22.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.55. It has decreased from 1.07 (Mar 24) to 0.55, marking a decrease of 0.52.
- For Current Ratio (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has increased from 1.38 (Mar 24) to 2.12, marking an increase of 0.74.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 0.87 (Mar 24) to 1.27, marking an increase of 0.40.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 4. It has decreased from 2.96 (Mar 24) to 2.31, marking a decrease of 0.65.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 9.87 (Mar 24) to 0.00, marking a decrease of 9.87.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 7.08 (Mar 24) to 0.00, marking a decrease of 7.08.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 90.13 (Mar 24) to 0.00, marking a decrease of 90.13.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.92 (Mar 24) to 0.00, marking a decrease of 92.92.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.58. This value is within the healthy range. It has decreased from 9.04 (Mar 24) to 8.58, marking a decrease of 0.46.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.33. This value is within the healthy range. It has increased from 2.15 (Mar 24) to 4.33, marking an increase of 2.18.
- For Enterprise Value (Cr.), as of Mar 25, the value is 8,962.37. It has increased from 4,605.33 (Mar 24) to 8,962.37, marking an increase of 4,357.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.68. This value is within the healthy range. It has increased from 1.81 (Mar 24) to 2.68, marking an increase of 0.87.
- For EV / EBITDA (X), as of Mar 25, the value is 21.63. This value exceeds the healthy maximum of 15. It has increased from 13.81 (Mar 24) to 21.63, marking an increase of 7.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.33. This value is within the healthy range. It has increased from 1.66 (Mar 24) to 2.33, marking an increase of 0.67.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 90.12 (Mar 24) to 0.00, marking a decrease of 90.12.
- For Price / BV (X), as of Mar 25, the value is 2.26. This value is within the healthy range. It has decreased from 3.67 (Mar 24) to 2.26, marking a decrease of 1.41.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.33. This value is within the healthy range. It has increased from 1.66 (Mar 24) to 2.33, marking an increase of 0.67.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 24) to 0.01, marking a decrease of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sudarshan Chemical Industries Ltd:
- Net Profit Margin: 1.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.64% (Industry Average ROCE: 11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.62% (Industry Average ROE: 9.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.33
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 71.7 (Industry average Stock P/E: 35.29)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.6
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | 7th Floor, Eleven West Panchshil, Pune Maharashtra 411045 | grievance.redressal@sudarshan.com http://www.sudarshan.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rajesh B Rathi | Chairman & Managing Director |
| Mr. Ashish Vij | Whole Time Director |
| Mr. Naresh T Raisinghani | Ind. Non-Executive Director |
| Mrs. Shubhalakshmi A Panse | Ind. Non-Executive Director |
| Mrs. Anu A Wakhlu | Ind. Non-Executive Director |
| Mrs. Sudha P Navandar | Ind. Non-Executive Director |
| Ms. Bhumika Batra | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Sudarshan Chemical Industries Ltd?
Sudarshan Chemical Industries Ltd's intrinsic value (as of 04 November 2025) is 774.31 which is 32.61% lower the current market price of 1,149.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 9,020 Cr. market cap, FY2025-2026 high/low of 1,604/796, reserves of ₹3,424 Cr, and liabilities of 9,672 Cr.
What is the Market Cap of Sudarshan Chemical Industries Ltd?
The Market Cap of Sudarshan Chemical Industries Ltd is 9,020 Cr..
What is the current Stock Price of Sudarshan Chemical Industries Ltd as on 04 November 2025?
The current stock price of Sudarshan Chemical Industries Ltd as on 04 November 2025 is 1,149.
What is the High / Low of Sudarshan Chemical Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sudarshan Chemical Industries Ltd stocks is 1,604/796.
What is the Stock P/E of Sudarshan Chemical Industries Ltd?
The Stock P/E of Sudarshan Chemical Industries Ltd is 71.7.
What is the Book Value of Sudarshan Chemical Industries Ltd?
The Book Value of Sudarshan Chemical Industries Ltd is 438.
What is the Dividend Yield of Sudarshan Chemical Industries Ltd?
The Dividend Yield of Sudarshan Chemical Industries Ltd is 0.39 %.
What is the ROCE of Sudarshan Chemical Industries Ltd?
The ROCE of Sudarshan Chemical Industries Ltd is 6.03 %.
What is the ROE of Sudarshan Chemical Industries Ltd?
The ROE of Sudarshan Chemical Industries Ltd is 3.07 %.
What is the Face Value of Sudarshan Chemical Industries Ltd?
The Face Value of Sudarshan Chemical Industries Ltd is 2.00.